Profile photo Miriam Koopman

Miriam Koopman

Full Professor

Strategic program(s):

Strategic program(s):

Contact

Research groups

Medical oncology colorectal cancer group

Research aim

To improve outcomes and quality of life for all patients with colorectal and anal cancer by developing and validating biomarkers, enhancing therapeutic strategies, refining patient selection, and studying real life treatment outcomes.

Go to group

Recent publications

Phase I Dose-Escalation Study Combining Irinotecan-Loaded Drug-Eluting Bead Chemoembolization with Yttrium-90 Glass Microspheres Radioembolization in Colorectal Liver Metastases (DEBIR90Y) Li Shen Ho, Ahmed Alsultan, Maarten L J Smits, Miriam Koopman, Rutger Bruijnen, Arthur J A T Braat, Kirk D Fowers, Matthew R Dreher, Guus M Bol, Marnix G E H Lam
Journal of Vascular and Interventional Radiology, 2026, vol. 37
Mapping the anatomical landscape of colorectal tumours Kenta Iguchi, Kentaro Yamazaki, Toshihiro Misumi, Hideaki Bando, Yuka Nishimura, Tomomi Nishikawa, Eiji Oki, Jean-Yves Douillard, Miriam Koopman, Eric Van Cutsem, Carsten Bokemeyer, Alan P Venook, Yoshihiko Maehara, Volker Heinemann, Chiara Cremolini, Goro Nakayama, Thierry André, Qian Shi, Aimery de Gramont, Takayuki Yoshino
European Journal of Cancer, 2026, vol. 244
Real-world patient-reported outcomes in stage II/III rectal cancer in the Netherlands. Renee A. Lunenberg, Frederieke H. van der Baan, Ingrid Franken, Femke P.C. Sijtsma, Geraldine R. Vink, Marloes A.G. Elferink, Susan Boklage, Martijn P.W. Intven, Jamie Garside, Miriam Koopman, Rob van Wuijtswinkel, Jeanine Roodhart
Journal of Clinical Oncology, 2026, vol. 44, p.65
Safety and early organ preservation outcomes after dose escalation with MR-guided radiotherapy for rectal cancer (preRADAR) H Eijkelenkamp, M E Verweij, G Grimbergen, M Tanaka, C M Kensen, T Janssen, T Vijlbrief, W M U van Grevenstein, L M G Moons, M Koopman, M M Lacle, M N G J A Braat, M Maas, E C J Consten, A Pronk, A B Smits, J T Heikens, S G Elias, H M Verkooijen, G J Meijer, A Couwenberg, M P W Intven
Clinical and translational radiation oncology, 2026, vol. 60
Image-based consensus molecular subtypes and colon cancer recurrence Evertine Wesselink, Dieuwertje E Kok, Maxime W Lafarge, Anne-Sophie van Lanen, Iris D Nagtegaal, Maxime Sulter, Miriam Koopman, Johannes H W de Wilt, Ellen Kampman, Viktor H Kölzer, Anne M May, Fränzel J B van Duijnhoven,
Cancer Epidemiology, 2026, vol. 103
Adenocarcinoma of the small intestine cohort Pascale J M Schafrat, Tim R De Back, Felice N Van Erning, Frederieke H Van der Baan, Geraldine R Vink, Miriam Koopman, Ruben S A Goedegebuure, Louis Vermeulen, Ignace H J T De Hingh, Dirkje W Sommeijer,
Acta oncologica (Stockholm, Sweden), 2026, vol. 65, p.363-369

External positions

Member of the Quality Committee - lid - NVMO

Board member - lid - Onconext

Member of the data science and cohorts boards - lid - UMC Utrecht

Vice-chair/secretary of the Dutch Colorectal Cancer Group - vicevoorzitter/secretaris - DCCG

Chair of newly established RWD and digital health working group - voorzitter - ESMO

Faculty member for the Gastro-Intestinal Tumours-colorectal - lid - ESMO

Chair of expertise group colorectal Cancer 'uitkomstgerichte zorg' - voorzitter - FMS

Chair of workpackage 'well defined patient cohorts' of the national growth fund grant application - voorzitter - Oncode accelerator

Leading member of the Health sciences group - lid - NWO-GWI

Expert member of committee 'regie op registers dure geneesmiddelen' - lid - Zorginstituut NL

CRC expert on platform for answering online CRC questions - expert op basis van vraag/antwoord - Kanker.nl

Participant in the international collaboration of ARCAD - Participant, integrating patient-level data - ARCAD

founder and PI of the Dutch Prospective CRC cohort study - founder and PI - PLCRC